Dow record close | Senate stimulus talks stall | Oxford vaccine approved in U.K.

The authorization of yet another coronavirus vaccine helped the broader market Wednesday regain its slight losses from the previous session.

VIEW IN BROWSER | SUBSCRIBE WED, DEC 30, 2020 EVENING BRIEF AS OF WED, DEC 30, 2020 • 04:21 ET DJIA 30409.56 +0.24% +73.89 S&P 500 3732.04 +0.13% +5.00 NASDAQ 12870.00 +0.15% +19.78   Most Active DOW NAME LAST CHG %CHG AAPL 133.72 -1.15 -0.85% INTC 48.75 -0.64 -1.30% MSFT 221.68 -2.47 -1.10% S&P 500 NAME LAST CHG %CHG AAPL 133.72 -1.15 -0.85% GE 10.71 +0.15 +1.42% AAL 16.15 +0.29 +1.83% NASDAQ NAME LAST CHG %CHG AAPL 133.72 -1.15 -0.85% TSLA 694.78 +28.79 +4.32% INTC 48.75 -0.64 -1.30%   EDITOR'S NOTE The authorization of yet another coronavirus vaccine helped the broader market Wednesday regain its slight losses from the previous session.   The Dow Jones Industrial Average rose 73 points, or 0.2%, to post a fresh record closing high. The S&P 500 advanced 0.1%, and the Nasdaq Composite climbed 0.2%.   Earlier Wednesday, a British regulator cleared a Covid vaccine developed by the University of Oxford and AstraZeneca for emergency use. This vaccine is cheaper to produce and does not require ultra-cold storage like Pfizer's and Moderna's.   Wall Street also weighed the prospects of greater coronavirus relief as lawmakers continued to disagree over direct payments to Americans.   The Senate currently has no plans to vote on a bill that would boost checks to $2,000 from $600. That measure was passed by the House late Monday. However, Senate Majority Leader Mitch McConnell introduced another bill that ties the increased payments to demands from President Donald Trump on tech and the election.   "While we're happy with the stimulus that we have thus far, it's likely that we're going to need additional stimulus because the rising Covid cases will likely lead to more regional lockdowns after the holidays," said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors. "If that's the case, and the economic data starts to disappoint, we could see" stay-at-home names outperform again in 2021.   Catch The News with Shepard Smith at 7 p.m. ET on CNBC. The nightly newscast provides deep, non-partisan coverage and perspective on the day's most important stories. Fred Imbert | CNBC Markets Reporter @foimbert TOP NEWS  Dow rises for the fourth time in five days, ekes out record closing high $2,000 stimulus checks likely doomed after McConnell refuses to separate them from unrelated Trump demands Covid live updates: 'Gilligan's Island' star Dawn Wells dies at 82 from Covid complications Oxford-AstraZeneca Covid vaccine approved by UK regulator  How the pandemic drove massive stock market gains, and what happens next Small caps haven't rallied like this since 1983, and a big pullback is likely in the new year Appeals court sends lawsuit over Trump financial records back to lower court Yemeni officials say blast at Aden airport kills 22, wounds 50 Half of U.S. states will raise their minimum wage in 2021—and more pay hikes could be on the way Three stocks that could benefit from a second round of stimulus checks   TOP VIDEO Romeo Power CEO on the electric vehicle boom and going public via SPAC   CNBC PRO These clean energy funds have more than doubled this year — here's what they own   SPECIAL REPORTS With bitcoin ticking over $28,000, now might be a good time to give some of it to charity Amazon to buy podcast maker Wondery   Unsubscribe Manage Newsletters Terms of Service Join the CNBC Panel Digital Products Feedback Privacy Policy   © 2020 CNBC LLC. All rights reserved. A property of NBCUniversal. 900 Sylvan Avenue, Englewood Cliffs, NJ 07632 Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes and Market Data and Analysis. Data also provided by THOMSON REUTERS